Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 160 participants.
Also called NCT02008448
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 160 participants
- Registry
-
NCT02008448
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States, Russia
- Registry status
- Unknown status
Technical summary
Registry record NCT02008448. Randomized; double masking; primary purpose treatment. Start 2013-06 (registry gives no type); primary completion 2015-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Endomyocardial Botulinum Toxin Injection in Patients With Persistent Atrial Fibrillation
- Condition
- Persistent Atrial Fibrillation
- Intervention (Procedure)
- Pulmonary vein isolation
- Intervention (Procedure)
- Linear Lesion Ablation
- Intervention (Drug)
- BT injection
- Lead sponsor
- Meshalkin Research Institute of Pathology of Circulation
Record details
- Record id
cardio:ct-nct02008448- Content hash
f5dc015c1bdf5cc864ba2feafbf49394bbc7050383b490f505a3366717f0e92c